1. Clinical Breast Cancer
Changing Natural History of HER2–Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies 
Louisa A. Mounsey, Allison M. Deal, Kevin C. Keith, Julia M. Benbow, Shlomit S. Shachar, Timothy Zagar, E. Claire Dees, Lisa A. Carey, Matthew G. Ewend, Carey K. Anders 
Clinical Breast Cancer 
DOI: /j.clbc
Copyright © 2017 The Authors Terms and Conditions

2. Figure 1
Overall Survival From Initial Breast Cancer Diagnosis by Year of Diagnosis
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions

3. Figure 2
Time From Initial Breast Cancer Diagnosis to First Metastatic Diagnosis by Year of Diagnosis
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions

4. Figure 3
Time From First Metastatic Diagnosis to Breast Cancer Brain Metastasis Diagnosis by Year of Diagnosis
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions

5. Figure 4
Time to Breast Cancer Brain Metastasis Diagnosis From Initial Breast Cancer Diagnosis by Year of Diagnosis
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions

6. Figure 5
Overall Survival After Breast Cancer Brain Metastasis Diagnosis by Year of Diagnosis
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions

7. Figure 6
Overall Survival After Breast Cancer Brain Metastasis Diagnosis by Receipt of HER2–Targeted Therapy
Clinical Breast Cancer DOI: ( /j.clbc )
Copyright © 2017 The Authors Terms and Conditions